Equities

Zhejiang Jiuzhou Pharmaceutical Co Ltd

Zhejiang Jiuzhou Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (CNY)40.14
  • Today's Change-2.07 / -4.90%
  • Shares traded5.80m
  • 1 Year change+33.67%
  • Beta0.9637
Data delayed at least 15 minutes, as of Jun 16 2021 08:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • 603456:SHH price moved over +1.24% to 42.40
  • 603456:SHH price rises above 50-day moving average to 42.40 at 15:07 BST

Key statistics

On Wednesday, Zhejiang Jiuzhou Pharmaceutical Co Ltd (603456:SHH) closed at 40.14, -17.05% below its 52-week high of 48.39, set on May 25, 2021.
52-week range
Today
26.69Jun 30 202048.39May 25 2021
Open42.48
High42.81
Low40.01
Bid--
Offer--
Previous close40.14
Average volume8.30m
Shares outstanding831.41m
Free float408.87m
P/E (TTM)77.41
Market cap35.09bn CNY
EPS (TTM)0.5453
CNY
Annual div (ADY)0.20
CNY
Annual div yield (ADY)0.47%
Div ex-dateJul 08 2020
Div pay-dateJul 08 2020
Data delayed at least 15 minutes, as of Jun 16 2021 08:00 BST.
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.